Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intraocular Lymphoma × pegfilgrastim × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 42 Neutropenia 26 Lymphoma 23 Lymphoma, Large B-Cell, Diffuse 12 Neoplasms 11 Lymphoma, Non-Hodgkin 11 Sarcoma 9 Lymphoma, Follicular 9 Lymphoma, Mantle-Cell 8 Leukemia 8 Hodgkin Disease 8 Leukemia, Lymphocytic, Chronic, B-Cell 7 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Multiple Myeloma 5 Lymphoma, B-Cell, Marginal Zone 5 Chemotherapy-induced Neutropenia 5 Rhabdomyosarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm Metastasis 4 Lymphoma, Large-Cell, Immunoblastic 4 Waldenstrom Macroglobulinemia 3 Urinary Bladder Neoplasms 3 Sarcoma, Synovial 3 Prostatic Neoplasms 3 Neurofibrosarcoma 3 Neuroblastoma 3 Leukemia, Myeloid, Acute 3

Interventions

Cyclophosphamide 9 fludarabine phosphate 8 Whole-Body Irradiation 8 Rituximab 8 Cyclosporine 8 Peripheral Blood Stem Cell Transplantation 7 Filgrastim 7 Mycophenolic Acid 6 Dexamethasone 5 Methotrexate 4 Etoposide 4 Vorinostat 3 Tacrolimus 3 Radiotherapy 3 Lenalidomide 3 Irinotecan 3 Cytarabine 3 Carboplatin 3 Busulfan 3 Bortezomib 3 laromustine 2 entinostat 2 Thiotepa 2 Therapeutics 2 Prednisone 2 Paclitaxel 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Flow Cytometry 2 Enzyme-Linked Immunosorbent Assay 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00074178 2017-04-21

Protocol-B

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡